Pharmacognosy


Pharmacognosy is the study of plants or other natural sources as a possible source of drugs. The American Society of Pharmacognosy defines pharmacognosy as "the study of the physical, chemical, biochemical, and biological properties of drugs, drug substances, or potential drugs or drug substances of natural origin as well as the search for new drugs from natural sources".

Description

The word "pharmacognosy" is derived from two Greek words: φάρμακον pharmakon, and γνῶσις gnosis or the Latin verb cognosco νώσκω, gi, meaning 'to conceptualize' or 'to recognize'.
The term "pharmacognosy" was used for the first time by the Austrian physician Schmidt in 1811 and 1815 by Crr. Anotheus Seydler in work titled
Analecta Pharmacognostica.
Originally—during the 19th century and the beginning of the 20th century—"pharmacognosy" was used to define the branch of medicine or commodity sciences which deals with drugs in their crude, or unprepared, form. Crude drugs are the dried, unprepared material of plant, animal or mineral origin, used for medicine. The study of these materials under the name
pharmakognosie was first developed in German-speaking areas of Europe, while other language areas often used the older term materia medica taken from the works of Galen and Dioscorides. In German the term drogenkunde'' is also used synonymously.
As late as the beginning of the 20th century, the subject had developed mainly on the botanical side, being particularly concerned with the description and identification of drugs both in their whole state and in powder form. Such branches of pharmacognosy are still of fundamental importance, particularly for pharmacopoeial identification and quality control purposes, but rapid development in other areas has enormously expanded the subject. The advent of the 21st century brought a renaissance of pharmacognosy and its conventional botanical approach has been broadened up to molecular and metabolomic level.
In addition to the previously mentioned definition, the American Society of Pharmacognosy also defines pharmacognosy as "the study of natural product molecules that are useful for their medicinal, ecological, gustatory, or other functional properties." Other definitions are more encompassing, drawing on a broad spectrum of biological subjects, including botany, ethnobotany, marine biology, microbiology, herbal medicine, chemistry, biotechnology, phytochemistry, pharmacology, pharmaceutics, clinical pharmacy and pharmacy practice.
All plants produce chemical compounds as part of their normal metabolic activities. These phytochemicals are divided into primary metabolites such as sugars and fats, which are found in all plants; and secondary metabolites—compounds which are found in a smaller range of plants, serving a more specific function. For example, some secondary metabolites are toxins used to deter predation and others are pheromones used to attract insects for pollination. It is these secondary metabolites and pigments that can have therapeutic actions in humans and which can be refined to produce drugs—examples are inulin from the roots of dahlias, quinine from the cinchona, THC and CBD from the flowers of cannabis, morphine and codeine from the poppy, and digoxin from the foxglove.
Plants synthesize a variety of phytochemicals, but most are derivatives:
A typical protocol to isolate a pure chemical agent from natural origin is bioassay-guided fractionation, meaning step-by-step separation of extracted components based on differences in their physicochemical properties, and assessing the biological activity, followed by next round of separation and assaying. Typically, such work is initiated after a given crude drug formulation is deemed "active" in a particular in vitro assay. If the end-goal of the work at hand is to identify which one of the scores or hundreds of compounds are responsible for the observed in vitro activity, the path to that end is fairly straightforward:
  1. fractionate the crude extract, e.g. by solvent partitioning or chromatography.
  2. test the fractions thereby generated with in vitro assay.
  3. repeat steps 1) and 2) until pure, active compounds are obtained.
  4. determine structure of active compound, typically by using spectroscopic methods.
In vitro activity does not necessarily translate to activity in humans or other living systems.

Herbal

In some countries in Asia and Africa, 80% of the population relies on traditional medicine for primary health care. Native American cultures have also relied on traditional medicine such as ceremonial smoking of tobacco, potlatch ceremonies, and herbalism, to name a few, prior to European colonization. Knowledge of traditional medicinal practices is disappearing, particularly in the Amazon.